Amgen To Buy Rare Diseases Drugmaker Horizon Therapeutics In $28.3 Billion DealInvestors Business Daily • 12/12/22
Amgen confirms to acquire Horizon Therapeutics in cash deal valued at about $27.8 billionMarket Watch • 12/12/22
AMGEN TO HOST WEBCAST INVESTOR CALL FOLLOWING ANNOUNCED ACQUISITION OF HORIZON THERAPEUTICSPRNewsWire • 12/12/22
Sanofi Says it does not intend to make an offer for horizon, leaving Amgen as sole bidderReuters • 12/11/22
Mirati Therapeutics Crashes As The Cancer Rivalry With Amgen Heats UpInvestors Business Daily • 12/06/22
Amgen Inc. (AMGN) World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease Conference (Transcript)Seeking Alpha • 12/05/22
Horizon Topples After J&J Pulls Out Of Bidding War, Leaving Amgen, SanofiInvestors Business Daily • 12/05/22
Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli LillyInvestors Business Daily • 12/01/22
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, SanofiInvestors Business Daily • 11/29/22
Amgen Inc. (AMGN) Presents at Evercore ISI HealthCONx Conference (Transcript)Seeking Alpha • 11/29/22